VG712

· Virogen Biotechnology Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for VG712, covering 2026-04-14 to 2026-04-14. Get the full timeline:

Most recent: Clinical Trial Update: A Study of VG712 in Patients With Mycosis Fungoides [Phase 2]